| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/11/18 | 06 : 07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/14 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/10 | 07 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 01 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 00 : 24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23 : 23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23 : 22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23 : 18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23 : 17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23 : 15 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 22 : 57 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 22 : 43 | GlobeNewswire Inc. | Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 06 : 08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/28 | 06 : 04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21 : 55 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21 : 48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21 : 30 | GlobeNewswire Inc. | Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/24 | 00 : 15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/24 | 00 : 11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/17 | 23 : 38 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |